Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Live music may soothe Alzheimer's patients and caregivers, yale study hints

NCT ID NCT06940687

First seen Feb 12, 2026 · Last updated Jun 22, 2026 · Updated 23 times

Summary

This study from Yale University will test whether listening to live music can reduce anxiety and improve brain activity in people with early Alzheimer's disease, dementia, or mild cognitive impairment, along with their caregivers. Sixty pairs (patient and caregiver) will attend both a live concert and a recorded music session while researchers measure their heart rate, brain waves, and facial expressions. The goal is to see if live music offers unique benefits for emotional well-being and connection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEMENTIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Firehouse 12 Studios

    New Haven, Connecticut, 06510, United States

  • Musical Intervention Studios

    New Haven, Connecticut, 06520, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Live music performance

What this could lead to

If it works, this could point toward a simple, drug-free way to ease anxiety and improve well-being for people with early Alzheimer's and their caregivers.

What could go wrong

This is a small, early-stage study with only 60 participants, so results may not apply to everyone. It measures brain activity and heart rate, not long-term disease changes, so benefits may be temporary.

Conditions

The condition(s) this trial relates to.

Alzheimer disease anxiety disorder Cognitive Dysfunction dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.